In AD, glial cells manifest heightened C/EBPβ levels due to sustained upregulation of pro‐inflammatory cytokines in the cortex, with a particularly notable increase observed in microglia.29, 30. The gene discussed is CEBPB; the disease is Alzheimer disease.